Browsing Centre for Biochemical Pharmacology by Author "Gilroy, D"
Now showing items 1-2 of 2
-
Asymmetric Synthesis and Biological Screening of Quinoxaline-Containing Synthetic Lipoxin A4 Mimetics (QNX-sLXms)
de Gaetano, M; Tighe, C; Gahan, K; Zanetti, A; Chen, J; Newson, J; Cacace, A; Marai, M; Gaffney, A; Brennan, E (American Chemical Society, 2021-06-17)Failure to resolve inflammation underlies many prevalent pathologies. Recent insights have identified lipid mediators, typified by lipoxins (LXs), as drivers of inflammation resolution, suggesting potential therapeutic ... -
Plasma lipid mediator (LM) profiling identifies hyper- and hypo-activated groups of patients with ACLF and targeted 20% human albumin solution infusion recalibrates abnormalities
China, L; Maini, A; Colas, R; Ly, L; Dalli, J; Gilroy, D; O'Brien, A; Infection, ATTIREAP (2017)